Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01347307 · ClinicalTrials.gov registry record · NA
Stereotactic Body Radiotherapy for Spine Tumors
A NA study of Meningioma and Chordoma, sponsored by Mercy Research.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT01347307 is a NA study of Meningioma and Chordoma that has completed, run by Mercy Research. The registered enrollment target is 38 participants, below the 98-participant average among 21 other Meningioma trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01347307, a NA study of Meningioma and Chordoma, has completed, sponsored by Mercy Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the local control rate as well as acute and late toxicity rates of stereotactic body radiotherapy (SBRT) for the treatment of spine metastases and benign spine tumors.
Conditions Studied
Interventions
- RADIATION SBRT for Benign Extradural Spine Tumors
- RADIATION SBRT for Vertebral/Paraspinal Metastases
Study Locations (1)
Missouri
- Mercy Medical Center, St. Louis - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2008-09 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01347307
The ClinicalTrials.gov registry entry for NCT01347307 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 98-participant average among 21 other Meningioma trials with a reported enrollment target (61% lower). The listed sponsor is Mercy Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Meningioma appearing as the primary indexed condition, and to 2 interventions - of which SBRT for Benign Extradural Spine Tumors is the first listed.
NCT01347307 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT01347307 about?
NCT01347307 is a clinical study titled "Stereotactic Body Radiotherapy for Spine Tumors". This study will evaluate the local control rate as well as acute and late toxicity rates of stereotactic body radiotherapy (SBRT) for the treatment of spine metastases and benign spine tumors.
What is the current status of trial NCT01347307?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2008-09. Estimated completion is 2017-09.
What conditions does trial NCT01347307 study?
This clinical trial studies the following conditions: Meningioma, Chordoma, Spinal Metastases, Neurofibroma, Schwannoma.
What interventions are being tested in trial NCT01347307?
The interventions under investigation include: SBRT for Benign Extradural Spine Tumors (RADIATION), SBRT for Vertebral/Paraspinal Metastases (RADIATION).
Who is sponsoring clinical trial NCT01347307?
This trial is sponsored by Mercy Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01347307 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Meningioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of the CONVIVO System
RECRUITING · NA
-
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
RECRUITING · NA
-
Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
RECRUITING · NA
-
A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas
ACTIVE NOT RECRUITING · NA
-
Information Presentation Formats
COMPLETED · NA
-
Abemaciclib in Newly Diagnosed Meningioma Patients
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.